Sign in

CIK 0000920148

  • Large accelerated filer

LABCORP HOLDINGS INC.

Sign in to watch
Ticker
LH
Exchange
NYSE
Industry
Services-Medical Laboratories
FY end
Dec 31
Entity type
Operating
EIN
992588107
Phone
+1 336-229-1127
Business address
358 S MAIN ST, BURLINGTON, NC, 27215
Former names
LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,241,708
in 3 filings, $108K under 10b5-1 plans

Net −$1,241,708. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-27 EISENBERG GLENN A Chief Financial Officer, EVP Option exercise +20,033 43,628
2024-03-27 EISENBERG GLENN A Chief Financial Officer, EVP Shares withheld for taxes −8,805 $216.57 $1.9M 34,823
2024-03-27 EISENBERG GLENN A Chief Financial Officer, EVP Option exercise · Restricted Stock Unit −20,033 15,706
2024-03-27 BERBERIAN LANCE EVP, CIO & CTO Option exercise +7,697 31,313
2024-03-27 BERBERIAN LANCE EVP, CIO & CTO Shares withheld for taxes −3,299 $216.57 $714K 28,014
2024-03-27 BERBERIAN LANCE EVP, CIO & CTO Option exercise · Restricted Stock Unit −7,697 2,100
2024-03-07 Schroeder Mark S EVP, Pres Diagnostics & COO Option exercise 10b5-1 +2,119 $117.09 $248K 10,084.14
2024-03-07 Schroeder Mark S EVP, Pres Diagnostics & COO Sale 10b5-1 −5,048 $218.45 $1.1M 5,036.14
2024-03-07 Schroeder Mark S EVP, Pres Diagnostics & COO Option exercise · Non-qualified Stock Options 10b5-1 −2,119 0
2024-03-07 Summy Amy B. EVP, Chief Marketing Officer Sale 10b5-1 −227 $218.45 $50K 3,859
2024-02-21 EISENBERG GLENN A Chief Financial Officer, EVP Option exercise +14,054 $163.63 $2.3M 58,099
2024-02-21 EISENBERG GLENN A Chief Financial Officer, EVP Sale −18,379 $215.37 $4.0M 39,720
2024-02-21 EISENBERG GLENN A Chief Financial Officer, EVP Sale −7,907 $215.68 $1.7M 31,813
2024-02-21 EISENBERG GLENN A Chief Financial Officer, EVP Sale −6,665 $217.52 $1.4M 25,148
2024-02-21 EISENBERG GLENN A Chief Financial Officer, EVP Sale −1,553 $217.98 $339K 23,595
2024-02-21 EISENBERG GLENN A Chief Financial Officer, EVP Option exercise · Non-qualified Stock Options −14,054 0
2024-02-21 DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl Sale −500 $215.49 $108K 3,400.55
2024-02-13 van der Vaart Sandra D EVP, Chief Legal Officer Sale 10b5-1 −237 $226.45 $54K 7,636.98
2024-02-12 Schechter Adam H President & CEO Shares withheld for taxes −1,231 $227.45 $280K 52,994
2024-02-12 EISENBERG GLENN A Chief Financial Officer, EVP Shares withheld for taxes −215 $227.45 $49K 44,045

Page 27 of 28 · 545 trades